Top 50 Biotech VC Funds & Investors in Ireland (October 2023)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
27 | Ireland, United States, United Kingdom | Seed, Series A | Software, Health Care, Information Technology | $429k–$12M |
|
Kernel Capital
VC Fund
|
9 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $536k–$9M |
|
Western Development Commission
VC Fund
|
8 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Medical | $696k–$8M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.2M–$55M |
|
AIB Seed Capital Fund
VC Fund
|
6 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $536k–$6.4M |
|
Seroba Life Sciences
VC Fund
|
5 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $1.2M–$37M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, Ireland | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Software | $6.4M–$536M |
|
Atlantic Bridge
VC Fund
|
4 | United States, Ireland, United Kingdom | Series A, Series B | Software, Information Technology, Artificial Intelligence | $2.5M–$25M |
|
Irrus Investments
VC Fund
|
3 | Ireland, Sweden, United States | Seed, Series A | Biotechnology, Health Care, Medical Device | $696k–$3.8M |
|
Atlantic Bridge University Fund
VC Fund
|
3 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Big Data | $804k–$12M |
|
Act Venture Capital
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Analytics | $804k–$13M |
|
The Yield Lab Europe
VC Fund
|
3 | Ireland, United Kingdom, France | Seed, Series A | AgTech, Agriculture, Biotechnology | $536k–$10M |
|
HBAN Medtech Syndicate
VC Fund
|
2 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | |
|
Lightstone Ventures
VC Fund
|
2 | United States, Ireland, Singapore | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5M–$95M |
|
SVG Ventures
VC Fund
|
2 | United States, Canada, Ireland | Pre-Seed, Seed | AgTech, Agriculture, Farming | $75k–$5.7M |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.5M–$55M |
|
Enterprise Equity
VC Fund
|
2 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Medical Device | $536k–$7.5M |
|
Infinity Capital
VC Fund
|
2 | United States, Ireland, Canada | Series B, Series D | Semiconductor, E-Commerce, Electronics | $4M–$50M |
|
MML Capital Partners
VC Fund
|
1 | United Kingdom, France, United States | Private Equity, Series A | Manufacturing, Packaging Services, Food and Beverage | $11M–$20M |
|
Ascent Capital
VC Fund
|
1 | India, United States, Ireland | Series C, Series B | Financial Services, Health Care, Manufacturing | $2.5M–$121M |
|
Covidien
VC Fund
|
1 | Ireland | Series A | Health Care, Biotechnology, Science/Engineering | |
|
Mayo Clinic Ventures
VC Fund
|
1 | United States, Ireland, China | Series A, Series B, Seed | Health Care, Biotechnology, Medical | $1.4M–$69M |
|
The Yield Lab
VC Fund
|
1 | United States, Argentina, Brazil | Seed, Series A, Convertible Note | Agriculture, AgTech, Biotechnology | $50k–$7.2M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, Germany | Grant, Series C | Biotechnology, Health Care, Pharmaceutical | $1.2M–$90M |
|
Inventages Venture Capital Investment Inc.
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B | Biotechnology, Health Care, Therapeutics | $2.3M–$19M |
|
EarlyBird
VC Fund
|
1 | Germany | Series B | Mobile, Payments, Software | |
|
ETV Capital SA
VC Fund
|
1 | Ireland | Health Care, Biotechnology, Data and Analytics | ||
|
Fulcrum Global Capital
VC Fund
|
1 | United States, Canada, Ireland | Series A, Series B | Science/Engineering, Biotechnology, Agriculture/Farming | $3.8M–$6.5M |
|
Cultivian Sandbox Ventures
VC Fund
|
1 | United States, Canada, Germany | Series A, Series B, Seed | Agriculture, Biotechnology, Farming | $2M–$42M |
|
New Enterprise Associates
VC Fund
|
1 | United States, India, China | Series B, Series A, Series C | Software, Science/Engineering, Health Care | $5M–$85M |
|
Claret Capital Partners
VC Fund
|
1 | United Kingdom, Germany, United States | Debt Financing, Series A | Software, Information Technology, Mobile | $1.6M–$32M |
|
Carbery Group
VC Fund
|
1 | ||||
|
Street Capital
VC Fund
|
1 | Ireland, United States | Seed | Medical, Automotive, Biotechnology | |
|
Third Swedish National Pension Fund
VC Fund
|
1 | Sweden, Denmark, Ireland | Post-IPO Equity | Biotechnology, Battery, CleanTech | $46M–$65M |
|
Furthr VC
VC Fund
|
1 | Ireland | Seed, Pre-Seed | Medical, Medical Device, Health Care | $857k–$3.9M |
|
Kreos Capital
VC Fund
|
1 | United Kingdom, Germany, United States | Debt Financing, Series B, Post-IPO Debt | Biotechnology, Health Care, Software | $5M–$85M |
|
Ascentifi
VC Fund
|
1 | Ireland | Series A | Medical Device, Medical, Hospital | |
|
The Foundry
VC Fund
|
1 | Ireland | Series A | Health Care, Biotechnology, Science/Engineering | |
|
Earlybird Venture Capital
VC Fund
|
1 | Germany, United States, United Kingdom | Series A, Seed, Series B | Software, Information Technology, Health Care | $1.2M–$40M |
|
VisVires New Protein
VC Fund
|
1 | Israel, Germany, The Netherlands | Series A, Series B, Seed | Biotechnology, Food and Beverage, Health Care | $5M–$105M |
|
Silicon Valley Bank
VC Fund
|
1 | United States, United Kingdom, Canada | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | $4M–$145M |
|
Alimentos Ventures
VC Fund
|
1 | Ireland | Seed | Farming, Aquaculture, Therapeutics | |
|
EarlyBirdCapital
VC Fund
|
1 | Ireland | Seed | Medical, Health Care, Biotechnology | |
| Life Sciences Partners | 1 | Series A, Series B, Series C | Health Care, Science/Engineering, Biotechnology | $5.4M–$70M | |
|
Carragh Holdings
VC Fund
|
1 | Ireland | Series A | Biotechnology, Bioinformatics | |
|
Cedas Foundation
VC Fund
|
1 | Ireland, United States | Seed | Biotechnology, Organic, Biopharma | |
|
KBI Biopharma
VC Fund
|
1 | United States, Ireland | Seed, Series A, Series D | Biotechnology, Life Science, Medical | |
|
Bank of Ireland Seed and Early Stage Equity fund
VC Fund
|
1 | Ireland | Seed, Series A | Software, Solar, Advertising | |
|
WxNW
VC Fund
|
1 | Ireland | Seed | Sales, Consumer, Marketing | |
|
Blue Wire Capital
VC Fund
|
1 | United Kingdom, United States, France | Seed, Pre-Seed, Convertible Note | Software, Art, Internet | $550k–$4.3M |
| Access all 50 VC funds in Ireland Biotech startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 383
- Round size: Seed $429k–$2.9M; Series A $2M–$12M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
- Tailr — Redefining production for the clothing industry.
- Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 86
- Round size: Seed $536k–$4.3M; Series A $1.4M–$9M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
- Causeway Sensors — The Affinity, is a compact, bench-top Biosensor providing accurate real-time analysis at an accessible price. The Affinity biosensor and accompanying Access Chip incorporate the latest advancements in Nanotechnology, providing the biochemistry researcher the perfect platform to explore the complex world of biomolecular interactions.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 32
- Round size: Seed $696k–$3.8M; Series A $4.7M–$8M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
- Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 40
- Round size: Series A $6.4M–$24M; Series B $5.4M–$48M; Series C $3.2M–$55M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
- Vivasure Medical — Medical device company developing a closure device for vascular access procedures.
- Ermium Therapeutics — Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of inflammation.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $536k–$3.2M; Series A $1.1M–$6.4M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — The only real-time media monitoring platform that predicts the stories and topics that will matter in the hours ahead.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning biotech innovations.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 35
- Round size: Series A $1.2M–$24M; Series B $4.6M–$37M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Sibylla Biotech — Sibylla Biotech developed small molecule folding interfering degraders (FIDs) that can address a range of therapeutic areas.
- Storm Therapeutics — Targeting pathways that modify RNA to deliver novel cancer therapeutics.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, Ireland
Investor stats
- Total investments: 202
- Round size: Post-IPO Debt $6.4M–$536M; Debt Financing $11M–$321M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Valmet — Valmet is the leading global developer and supplier of technologies, automation and services for the pulp, paper and energy industries.
- CTP — CTP NV is a real estate company that owns and develops industrial and logistics parks.
- Cofina Ivory — Cofina Ivory is a savings and credit institution that operates in the sector of mesofinance.
Atlantic Bridge is a growth equity technology Fund with offices in Dublin, London, Palo Alto, Beijing, and Hong Kong. They focus on Middle Market Technology investments across Europe, with a strong emphasis on a transatlantic business building and investment exit model. We focus on making domain-specific investments in growth-stage companies,specifically in sectors such as Artificial Intelligence, Machine Learning, Robotics, Computer Visioning, IoT, Big Data, etc.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the US, and Asia. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in the US and Chinese markets. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 110
- Round size: Series A $5M–$25M; Series B $2.5M–$22M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $86M in 2021
Portfolio highlights
- Mitiga — Mitiga proactively stores and enhances forensic data so our experts can start incident investigations fast to get you back to business as usual
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 19
- Round size: Seed $696k–$3.8M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 28
- Round size: Seed $804k–$3.8M; Series A $3.1M–$12M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- ProVerum Medical — ProVerum Medical is an early stage medical device startup for the treatment of Benign Prostatic Hyperplasia (BPH).
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 132
- Round size: Seed $804k–$3.3M; Series A $2.4M–$13M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Oblivious — Oblivious builds tools to allow you to use your sensitive data with internal and external partners while keeping it private and secure.
- Everyangle — Everyangle facilitates business in computer vision applications based on cisco meraki MV smart cameras across retail and industrial firms.
- Spectrum Life — Spectrum.Life's comprehensive solution enables organisations to provide a workplace wellbeing programme that can have a substantially positive impact on their health and wellness, as well as on the culture and performance of the company.
The Yield Lab Europe is a €50m early stage Agrifood and Ag Tech fund which comprises an accelerator and a larger follow-on fund, investing in high tech companies with the potential to significant disrupt and improve our current systems of global food production, and to improve the environmental sustainability of the industry. The main fund invests€1m each into 10-12 companies over several follow on rounds, with the strongest accelerator companies expected to progress to the main fund. The Yield Lab Europe is also part of a global network of Agrifood Tech funds, with global headquarters in St Louis USA, and sister funds in LATAM and Singapore.
Show more...Investment focus
- Industry: AgTech, Agriculture, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 27
- Round size: Seed $536k–$2M; Series A $3.8M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $54M in 2021
Portfolio highlights
- Skytree — Transforming Carbon Removal for stable, reliable and sustainable CO2 supply
- BiOceanOr — BiOceanOr provides underwater weather stations to measure water quality. Their solutions provide informations from your exploitation in real-time. Receive alerts in real-time and take decisions with their preventive alert system.
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Signum Surgical — Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that developbetween the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 64
- Round size: Series A $5M–$95M; Series B $7.5M–$90M; Series C $20M–$73M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
- Relievant Medsystems — Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.
- Tagworks Pharmaceuticals — As pioneers of Click-to-Release technology, we are revolutionizing cancer treatment using in vivo click chemistry to increase the therapeutic window of powerful cancer therapies.
We work with leading corporations, startups, universities, and growers to solve the biggest challenges facing the agtech and foodtech industries.
Show more...Investment focus
- Industry: AgTech, Agriculture, Farming
- Stage:Pre-Seed, Seed
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 91
- Round size: Seed $100k–$5.7M; Pre-Seed $75k–$100k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- FarmWise — FarmWise provides technology-based services that allow farmers to streamline farm operations and increase food production efficiency.
- Napigen — We are the genome editing company specialized for mitochondrial engineering. We address unmet needs of future food supplies by creating hybrid crop plants to boost their yields to an unprecedented level. The company’s technology creates robust male sterile lines that are ideal over conventional lines because of their stability and elitebackgrounds. This allows the production of non-GM hybrid seeds in crop plants that are currently mostly non-hybrid such as wheat. Our technology solution is expected to fulfill the highest level of public acceptance and aspiration.
- Muddy Machines — Muddy Machines is working on field robots to help farms manage labor-intensive crops by completing the fieldwork.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 109
- Round size: Series A $5.5M–$55M; Series B $20M–$54M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Hemab — Hemab is pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Medical Device
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $536k–$2.1M; Series B $2.5M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — https://metabolomicdiagnostics.com/ A deep-tech company specialized in the development of biomarker-based diagnostic solutions
Infinity Capital are hypothesis-driven investors - constantly calibrating ideas through a Silicon Valley/technology network that they've been building for over two decades. Their extensive technology and operating backgrounds, combined with over a dozen years each of successful startup investing, have been essential in buildingcredibility and a reputation that resonates with entrepreneurs.
Show more...Investment focus
- Industry: Semiconductor, E-Commerce, Electronics
- Stage:Series B, Series D
- Geography: United States, Ireland, Canada
Investor stats
- Total investments: 33
- Round size: Series B $9M–$50M; Series D $4M–$17M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- AltraTech — Next Generation Molecular Detection Discover Altratech Next Generation Molecular Detection Discover Altratech At Altratech, our mission is to enable next generation molecular detection.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
- Core Starters — Core Starters services startups and investors through blockchain-based decentralized services to solve real problems.
MML Capital Partners is an independent investment firm, with over twenty years of history, focused on providing capital to businesses for expansion/acquisitions, management-led equity deals, recapitalisations and buy-outs.
Show more...Investment focus
- Industry: Manufacturing, Packaging Services, Food and Beverage
- Stage:Private Equity, Series A
- Geography: United Kingdom, France, United States
Investor stats
- Total investments: 26
- Round size: Private Equity $11M–$20M
- Lead/follow: 77% lead, 23% follow
- Last fund: Likely still investing — raised $718M in 2021
Portfolio highlights
- Global Packaging Services — Reusable metal crate multi-way packaging solutions, reusable metal crate multi-way packaging solutions.
- Ross-shire Engineering — Engineered Solutions for the Treatment & Purification of Water from RSE (Ross-shire Engineering).
- Virginia International Logistics — Virginia International Logistics provides temperature controlled, dry freight, and containerized logistics across Ireland, UK and Europe.
Ascent Capital is a leading India-focused independent private equity firm. They are one of the most experienced teams on ground with over 150+ years of collective experience in Indian capital markets. Over the past 15 years they have helped over 55 entrepreneurial teams build leading businesses across diverse sectors such as Technology, Ecommerce,Healthcare, Financial Services, Consumer Brands, Infrastructure, etc.
Show more...Investment focus
- Industry: Financial Services, Health Care, Manufacturing
- Stage:Series C, Series B
- Geography: India, United States, Ireland
Investor stats
- Total investments: 38
- Round size: Series B $12M–$33M; Series C $2.5M–$121M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- Haber — We provide automation solutions for the Pulp and Paper Industry. We have expertise in process automation for chemical dosing. Our solutions are scalable to food and beverage, institutions with HVAC applications as well as metals and mining industries.
- EnKash — Enkash is now Asia's 1st and Smartest Spend Management Platform that offer services like Account Payable, Accounts Receivable, Expense Management & many more.
- MyGlamm — MyGlamm is a direct-to-consumer beauty brand that offers an online beauty products marketplace with international spa and salon products. The company uses a combination of technology, content, and social media to allow consumers to not only discover its products but also create rich, personalized, content and tutorial.MyGlamm was founded in 2015and is headquartered in Mumbai, Maharashtra.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments: Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry andmonitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products; Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM). The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups: - Endomechanical Instrumentsâ includes its laparoscopic instruments and surgical staplers. - Soft Tissue Repair Productsâ includes its sutures, mesh and biosurgery products. - Energy Devicesâ includes its vessel sealing, electrosurgical and ablation products and related capital equipment. Oximetry and Monitoring Productsâ includes its sensors, monitors and temperature management products. Airway and Ventilation Products—includes its airway, ventilator, breathing systems, sleep and inhalation therapy products. Vascular Devicesâ ”includes its compression and vascular therapy products. SharpSafety Productsâ includes its needles, syringes and sharps disposable products. Clinical Care Productsâ includes its urology, enteral feeding and other advanced woundcare products.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Science/Engineering
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Seed
- Geography: United States, Ireland, China
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$8.2M; Series A $5M–$26M; Series B $6.5M–$69M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Turtle Health — Turtle Health is a virtual fertility counselling clinic. We provide you with personalized, medically meaningful information to help you plan your fertility journey, early and affordably.
- The Patient Company — The Patient Company provides clinical staff members with an automated lateral patient transfer device called SimPull. The company was founded in 2019 by Andrew Heuerman and is based in Grand Rapids, Michigan.
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
The Yield Lab invests in AgriFood Tech companies with technologies focused on crops, animal health, digital agriculture, logistics, and food ingredients. Initial investments range from $100,000 – $1.5M.
Show more...Investment focus
- Industry: Agriculture, AgTech, Biotechnology
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Argentina, Brazil
Investor stats
- Total investments: 54
- Round size: Seed $100k–$4M; Series A $950k–$7.2M; Convertible Note $50k–$1.2M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Seedz — Seedz is a platform that brings farmers, resellers, rural producers, and agricultural entrepreneurs together boost agri - industry.
- Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
- Ascribe Bioscience — Ascribe develops natural crop protection products that help farmers reduce disease and increase yield without harming the environment or human health.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Grant $1.2M–$6.8M; Series C $10M–$90M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Inventages Venture Capital Investment Inc is an investment arm of Nestle SA specializing in PIPES, seed, early, mid, and late venture investments. The firm seeks to invest in middle market and mature companies. It provides mezzanine and bridge financing. The firm seeks to invest in health care, life sciences, cosmeceuticals, pharmaceuticals,enabling technologies and services, and diagnostic and medical devices. Within the pharmaceutical sector, it typically invests in small molecules, proteins, antibodies, vaccines, phytopharmaceuticals, natural compounds, botanicals, antibiotics, and therapeutics. Within the diagnostic sector, it focuses on genetic materials, biomarkers, pathological markers, genetic profiles, protein profiles, pharmacogenomics, food and environmental safety, genetically modified organism detection and trading, medical monitoring, diagnostic and analytical tools, and quality control. Within enabling technologies and services it primarily invests in novel packaging, process and production technologies, supply chain management, innovative materials and resources, delivery systems for active compounds, encapsulation and prevention, food services, extraction and fractionation of biological materials, consumer relation management, green biotechnology, smell and taste modifying technologies, genomics, proteomics, metabolomics, screen and characterization technologies, chemical and biological engineering, and innovative preventive and therapeutic concepts. It also invests in companies involved in the prevention of medical foods, nutraceuticals, cosmoceuticals, nutrition, innovative food, functional food, dietary and food supplements, oral and skin care, immune modulation and stimulation, and health and disease management.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 37
- Round size: Series A $2.3M–$18M; Series B $5.6M–$19M
- Lead/follow: 65% lead, 35% follow
- Last fund: May invest from a new fund soon — last raise in 2006
Portfolio highlights
- Accera — Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment. It was founded in 2001 and is headquartered in Broomfield, Colorado.
- XOLUTION — XOLUTION is the most advanced reclosable beverage container solution. Already in its prototype state, the new XO resealable can won the Can of the Year Award in Dubai in 2009 (Winner Silver - Category Prototype) and was enhanced and refined since, involving extensive market research and field testing. With the can now entering the consumer beveragemarket, they are confident that the product resembles a step forward for XOLUTION in becoming the market leader in this field. XOLUTION GmbH is headquartered in Munich, Germany. In 2008, Marc von Rettberg was named Chief Executive of the company. He joined Christian Bratsch, Vice President R&D, to introduce innovative designs to the beverage packaging industry for reclosable beverage cans.Rettberg and Bratsch established new product design guidelines with a clear focus on values and benefits for the entire supply chain. The innovative beverage can ends were required to offer easy usage to the consumer (intuitive, easy to open and reseal), easy integration for the beverage filler in the existing processes (no major adjustments to the filling line), easy handling for the can maker (XO reclosable can ends based on standard shells), and improved commercialization for the beverage brand (unique branding options). And, of course, the focus was set on providing these benefits at a reasonable overall cost.In 2009, Can Maker Magazine recognized the XOLUTION innovative resealable can with the Silver Award in the Prototype category for the XO-400 reclosable beverage can lid. Since Time-to-Market is a key challenge for all innovators, Rettberg and Bratsch have created a competitive advantage of rapid prototyping and testing capabilities in their Salzburg R&D Center. XOLUTION GmbH is managed by one of the most competent teams in the business. With long-term experiences in their respective fields, their leading specialists guarantee the best coverage of all business areas from prototyping, R&D and product management to trading and distribution. With their knowledge, the XO Resealable Can was successfully converted from a simple vision to a technologically sophisticated product that will have a significant influence on the canned beverage market.
- Ripple Foods — Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar. Ripple has 8x the protein of almond milk and half the sugar of dairy milk. It’s high in bioavailable calcium (50% more than milk), potassium and provides a good source of omega-3s. It’s lower in calories than milk and best of all, it has thecreamy, delicious texture our dairy-free friends are missing. No more thin, chalky almond/ soy/ cashew milk.It was founded in 2014 and headquartered in Emeryville, California.
EarlyBird is a postal snacking service that delivers healthy snacks to its users’ doorstep. It provides its users with TasteBox, 5 healthy snacks and 2 unique teas, to help them through the working week. Its TasteBox also contains music and art from up and coming artists. EarlyBird was launched in 2014 and is based in London, England.
Show more...Investment focus
- Industry: Mobile, Payments, Software
- Stage:Series B
- Geography: Germany
Investor stats
- Total investments: 6
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- finmid — Scale bigger by building your business on finmid's lending infrastructure. Our APIs enable tech companies to offer credit cards, transaction-based lending, and working capital to their business customers.
- Noscendo — Noscendo operates as a diagnostics company dedicated to the identification and assessment of bloodstream-associated pathogens and other infections.
- Goodlegal — Goodlegal serves as a one-stop shop for all legal requirements. It focuses on compliance, it should be able to compete with in-house lawyers, who handle an organization's internal legal matters, and law firms on both ends of the legal spectrum.
ETV is one of Europe's leading providers of debt financing solutions for venture capital backed technology and healthcare businesses. Founded in 1999, ETV has a long and successful track record of investing in technology or intellectual property based companies across Europe and Israel, diversified by industry and development stage. Theyseek to set their selves apart from other venture lenders by being supportive, flexible and responsive to the needs of their customers, and a testament to their approach is the number of serial entrepreneurs, business angels and senior management that have come back to ETV both through the lifecycle of a company’s growth and for their subsequent ventures.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Data and Analytics
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- 123.TV — German television channel, 123TV organizes cross-media auctions (TV and internet) on consumer products, for a public of all generations. The auction is reversed in the sense that the price fixed in advance to steady decreases over time until the amounts passed.
- Nallatech — Nallatech Ltd. provides FPGA computing solutions for defense and security market. It offers FPGA computing motherboards, FPGA computing modules, software and IP cores, and HPC products. The company offers its products through sales team in the United States and the United Kingdom. Nallatech Ltd. was formerly known as Nallatech Worldwide Limitedand changed its name in May 2008. The company was founded in 1993 and is based in Glasgow, United Kingdom with regional offices in San Jose, Los Angeles, Philadelphia, and Boston. As of May 2, 2008, Nallatech Ltd. operates as a subsidiary of Interconnect Systems, Inc.
- Stokes Bio — Stokes Bio develops and distributes microfluidic technology to its clients. It was founded in 2005 and is based in Ireland. It was acquired by Life Technologies in 2010.
Feeding the world one investment at a time
Show more...Investment focus
- Industry: Science/Engineering, Biotechnology, Agriculture/Farming
- Stage:Series A, Series B
- Geography: United States, Canada, Ireland
Investor stats
- Total investments: 12
- Round size: Series A $3.8M–$6.5M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Vytelle — Vytelle is a company with a deeper purpose and revolutionary technology that helps to advance bovine, deer and buffalo genetics faster by redefining reproduction.
- P&P Optica — P&P Optica Inc. is a food processing solutions company located in Waterloo Ontario, Canada. What was once a prominently research driven company has now expanded out into the fields of industrial process solutions with their innovative array of chemical imaging spectrometers. PPO provides industrial application solutions in the Food processingindustry, and other similar industries to:Increase food safety: through detection of foreign materials (such as plastics).
- Plastomics — Plastomics is a biotechnology startup that focuses in developing the next generation of crops by using chloroplast genetic engineering. Its technology platform is applicable to different crops and traits. Plastomics provides solutions for the many current industry challenges.The company was founded in 2016 and headquartered in St. Louis,Missouri.
Cultivian Sandbox is a venture capital firm focused on building next-generation disruptive agriculture and food technology companies capable of generating superior returns. As early investors and active board members, we employ a hands-on approach to building companies and are often directly involved in setting company strategy, recruiting keyexecutives, and raising additional capital. Much more than simply a financial resource, we are capable of delivering tremendous value though active collaboration with our strategic partners and network, which are unparalleled in the agriculture and food industries.As both experienced operating managers and venture investors we add value to portfolio companies both through our highly skilled team and extensive industry network. Our investment team combines the domain expertise and investment experience from Cultivian Ventures and Sandbox Industries. Our expertise in sourcing, evaluating, closing, managing and ultimately exiting successful equity investments positions us not only to build stronger businesses, but reshape industries.
Show more...Investment focus
- Industry: Agriculture, Biotechnology, Farming
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Germany
Investor stats
- Total investments: 43
- Round size: Seed $2M–$5M; Series A $2M–$23M; Series B $12M–$42M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Full Harvest — Waste less, profit more. Source imperfect and surplus fruits and vegetables up to 10-30% off.
- Debut — Debut Biotech is a biotechnology company that focuses on providing specialty enzyme solutions combined with continuous manufacturing. It combines the power of enzymes with continuous manufacturing to create and modify small and large molecules for a wide range of industries and applications.The company was founded in 2019 and is based in SanDiego, California.
- Leaf Agriculture — Leaf is a data network that connects apps and services to farm data from equipment, sensor, and software platforms.Leaf’s API allows developers to easily validate grower consent, access high-quality agriculture data, and scale their products. With Leaf, developers are building a food system that makes it healthier, increases farmers’ profits,benefits the environment, and is accessible to everyone.
New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.
Show more...Investment focus
- Industry: Software, Science/Engineering, Health Care
- Stage:Series B, Series A, Series C
- Geography: United States, India, China
Investor stats
- Total investments: 1277
- Round size: Series A $5M–$43M; Series B $8M–$62M; Series C $11M–$85M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- OP3N — Founded in 2021 as a subsidiary of EST Media Holdings, OP3N is the global Web3 superapp that serves as a one-stop-shop for all communication, connection and commerce with on-chain interactions in a simple unified interface. With a mission to create a more frictionless, decentralized and democratized creator economy on a global scale, OP3Nconsolidates the tools needed to mint, share and engage with digital goods and digital tokens into one vertical stack. OP3N’s leadership team leverages its cross-industry expertise from the entertainment, gaming and tech ecosystems, to lay the foundations for a new era of community-driven, inclusive entertainment while bringing everyone together on a journey into Web3. OP3N is co-led by media executive, artist, and serial entrepreneur Jaeson Ma, who has a successful track record launching companies including EST Studios, Stampede Ventures, East West Ventures, and 88rising, and who’s raised capital and advised on transactions totaling over $1 billion; and Eric Tu, an award-winning development executive who’s worked with major brands including Nike, Beats by Dre and Google, and as an Executive Producer with Bjork, Radiohead, Kendrick Lamar and more. The company is headquartered in Los Angeles. For more information, please visit: https://op3n.world.OP3N’s portfolio of projects includes a partnership with Tokyo fashion label AMBUSH; an intergalactic children’s book from Grimes; a partnership with entertainment icon Simon Fuller to produce an innovative musical film with the global pop group Now United; and the “Maybe You’re the Problem” music video from the singer-songwriter Ava Max, directed by the celebrated music video director Joseph Kahn.
- Workera — Workera is the precision upskilling platform helping enterprises, governments and individuals upskill and reskill to meet the critical demand for key technological capabilities including data science, machine learning and artificial intelligence. The Workera platform provides AI-driven mentorship at scale with its adaptive assessments andpersonalized learning plans that drive measurable results to close the skills gap.
- Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Claret Capital provides specialty debt financing to European growth businesses, predominantly in the technology, life sciences and environmental sectors. Typical loan sizes range from €1M-€40M with the flexibility to do larger transactions opportunistically.They look for investment opportunities in high growth business with proven managementteams in need of capital to fuel organic growth, acquisitions, equipment purchases, bridge loans and various forms of recapitalization.
Show more...Investment focus
- Industry: Software, Information Technology, Mobile
- Stage:Debt Financing, Series A
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 89
- Round size: Series A $2M–$6M; Debt Financing $1.6M–$32M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $318M in 2022
Portfolio highlights
- Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
- Holidu — Holidu is a search engine for vacation rentals. Search and compare more than 15 million vacation homes and save up to 55% on identical accommodations.
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
Pioneering research and expertise in action. Through innovati drive new product innovation that creates value for our.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.
Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale lender, Street Capital doesn’t have an expensive branch network and as such can pass those savings to the consumer. Street Capital prides itself on offering consumers competitive products and interest rates with an exceptional level of service.Havingapproved lender status with Canada Mortgage and Housing Corporation (CMHC) Street Capital is able to offer a broad spectrum of residential mortgage financing products to the consumer. Also, since we’re primarily focused on the mortgage broker origination channel, you’re assured that your mortgage will fit your needs comfortably.By continually working to develop innovative lending solutions and working in partnership with your local mortgage brokers, Street Capital is proud to help more Canadians realize their dreams of home ownership and enhancement.
Show more...Investment focus
- Industry: Medical, Automotive, Biotechnology
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Biosensia — Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing. RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications. Its componentchip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.
- Drive Time Metrics — Drive Time Metrics is developing innovative new revenue streams from connected car data, and helping automotive OEMs monetize their connected vehicle platforms.
Third Swedish National Pension Fund employs different investment strategies in the interest of spreading risk and protecting pensions for current and future pensioners. The firm was founded in 2001 and is headquartered in Stockholm, Sweden.
Show more...Investment focus
- Industry: Biotechnology, Battery, CleanTech
- Stage:Post-IPO Equity
- Geography: Sweden, Denmark, Ireland
Investor stats
- Total investments: 4
- Round size: Post-IPO Equity $46M–$65M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Saniona — Improving the lives of rare disease patients around the world through scientific innovation.
- Northvolt — Northvolt develops sustainable lithium-ion batteries in conjunction with R&D, industrialization, and recycling to support clean energy. It provides electrification and renewable energy storage designed for lithium-ion battery plant to produce batteries for electric vehicles. Northvolt's product is an environment-friendly batterymanufactured with minimal carbon footprint and with recycling technology without compromising with important eco-systems, enabling the auto industry to replace fossil fuels with electricity in an efficient manner. The company aims to establish a supply of sustainable battery cells and systems.In 2016, Paolo Cerruti and Peter Carlsson headquartered the company in Stockholm, Stockholms Lan.
- Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Furthr VC invests in transformative tech. Furthr Venture Capital invests in scalable, early-stage companies. We help Ireland's next generation of technology.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $857k–$3.9M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $34M in 2019
Portfolio highlights
- Klearcom — Klearcom tests the full customer call path from domestic phone number through the IVR Interactive Voice Response for connectivity and voice quality, validating voice call paths ensuring the connection between customer and agent is always reachable and accessible, software telecommunications IVR testing voice
- UrbanFox — UrbanFox protects online retailers against new forms of stealth fraud by analysing and learning from existing legitimate and fraudulent customer behavioural patterns.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
Kreos Capital provides innovative and flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Debt Financing, Series B, Post-IPO Debt
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 127
- Round size: Series B $8M–$85M; Post-IPO Debt $5M–$21M; Debt Financing $5M–$70M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Qover — Plug & play solutions empowering any digital business to integrate insurance into its strategy. Our promise? A tailored insurance experience, right when your customers need it most.
- Abivax — Abivax recently presented impressive 9-month interim extension data from studies of ABX464 in ulcerative colitis during an oral presentation at DDW 2019, demonstrating a continued duration of beneficial effect in patients after 11-months of treatment. View the conference presentation, here:
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Medical Device, Medical, Hospital
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
The Foundry, LLC is the premier medical device company incubator. We work with inventors to rapidly transform their concepts into companies by providing an incomparable combination of leadership, an experienced, multi-disciplinary team, a state-of-the-art facility and an extensive funding network. The Foundry Team is comprised of veteran medicaldevice entrepreneurs and investors with real world experience—and success—in developing world class medical device companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Science/Engineering
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Founded in 1997, Earlybird invests in all development and growth phases of technology companies. Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets. With EUR 2 billion under management,eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 247
- Round size: Seed $1.2M–$14M; Series A $2M–$26M; Series B $4.8M–$40M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Binalyze — Binalyze enhances all your digital forensics and incident response processes at max speed.
- ColibrITD — Quantum Computing Software Algorithm
- Re-Fresh Global — Re-Fresh Global brings sustainability innovation into the manufacturing industry. Our patented biotechnology transforms textile waste into recycled raw materials: nanocellulose, ethanol, and sanitized textile pulp.
VisVires New Protein is a pioneering investor focused on solving the persistent challenges of our food and feed system.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Health Care
- Stage:Series A, Series B, Seed
- Geography: Israel, Germany, The Netherlands
Investor stats
- Total investments: 23
- Round size: Seed $5M–$11M; Series A $5M–$12M; Series B $5.9M–$105M
- Lead/follow: 52% lead, 48% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- In Ovo — We are on a mission to improve animal welfare in the poultry sector, and we have the technology to make it happen.
- Nuritas — Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the mosthealth-benefiting components hidden within food, called bioactive peptides.
- Collectiv Food — Collectiv Food is a next generation food supplier, helping professional kitchens through increased reliability, cost savings, and greater sustainability.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 374
- Round size: Series A $4M–$30M; Series B $5.5M–$42M; Debt Financing $5M–$145M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- SafeRide Health — SafeRide Health provides technology-forward non-emergency medical transportation (NEMT) services for care providers and health plans offering Medicare Advantage and Medicaid. We intelligently improve and simplify NEMT to improve health outcomes and healthcare satisfaction.
- Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
- Olema Oncology — At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Accelerate innovation in aquaculture feed and technology.
Show more...Investment focus
- Industry: Farming, Aquaculture, Therapeutics
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- MicroSynbiotiX — Microsynbiotix, an Irish-based Biotechnology company making microalgal oral vaccines for aquaculture
EarlyBirdCapital, Inc. (“EBC”) is a registered broker-dealer1 and member of the Financial Industry Regulatory Authority, Nasdaq Stock Market, Inc., Municipal Securities Rule Making Board, and Securities Insurance Protection Corporation2. EBC is a boutique investment bank that has developed an expertise in working with smaller capitalizationcompanies, special situation investments and Special Purpose Acquisition Companies (SPACs:tm:), a new concept they pioneered and developed that involves publicly-traded, industry-specific acquisition funds.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP's management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example,LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming. With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe's largest and most experienced specialist life-science investors.
Show more...Investment focus
- Industry: Health Care, Science/Engineering, Biotechnology
- Stage:Series A, Series B, Series C
Investor stats
- Total investments: 123
- Round size: Series A $6.4M–$50M; Series B $5.4M–$69M; Series C $10M–$70M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — raised $279M in 2023
Carragh Holdings
Show more...Investment focus
- Industry: Biotechnology, Bioinformatics
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Kastus Technologies — Kastus is embedded into glass during manufacturing. Creating the world's first surface that constantly cleans itself of over 99% of germs and viruses, including Covid 19. It works 24/7, for the lifetime of the glass.
Cedas Foundation
Show more...Investment focus
- Industry: Biotechnology, Organic, Biopharma
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Hexafly — Hexafly is a biotechnology company that develops materials and sources form insects for aquafeed, chitin, and plant nutrition industry. It offers products from the sustainable farming of insects such as insect oil, protein, frass, and chitin. The company was founded in 2016 and headquartered in Kells, Meath, Ireland.
- BioSapien — BioSapien is a pre-clinical biotech company developing novel biodegradable implantable products that deliver active pharmaceutical ingredients (APIs) for oncology indications with reduced systemic side effects. The applications for this technology are currently under investigation for pancreatic cancer and lung cancer. The intended pipeline ofindications is expected to expand into other cancers such as colorectal, breast, and stomach cancers. BioSapien's 3D-printed MediChip delivers FDA-approved toxic high-dose systemic therapies in a localized slow-release biodegradable mesh which is able to target tissues while improving patients' quality of care and life.
KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.With each of our 300+ client partners, we have worked closely to personalize and rapidly accelerate their drug developmentprograms. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs.We have locations in Durham and Research Triangle Park (NC), Boulder and Louisville (CO), The Woodlands (TX), San Diego (CA), and Leuven, Belgium.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Medical
- Stage:Seed, Series A, Series D
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
- GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
- ReForm Biologics — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.
The Bank of Ireland Seed and Early Stage Equity fund is a joint fund built with contributions from the Bank of Ireland, the University of Limerick Foundation, and government-backed The seed fund will invest in export-oriented high potential firms that operate in the technology, food and financial services sectors, inaddition to supporting patent and patent pending projects within Irish universities, targeting investments between EUR 100K-500K. The new fund comprises of a €17 million investment by Bank of Ireland, along with funding of €8 million from Enterprise Ireland and € 1million by the University of Limerick Foundation. It will be managed by
Show more...Investment focus
- Industry: Software, Solar, Advertising
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 7
- Lead/follow: no public data
Portfolio highlights
- Pulsate — Pulsate enables direct communication with customers based on their location, context, interests and behaviours. Pulsate allows you to design and push rich media content directly to customers devices. Deepen the relationship by establishing a customer dialogue. Allow users to reply to your campaigns, provide feedback and keep complaints outside ofsocial media. Maximize foot traffic by targeting street level or competitor locations. Combine with segmentation for optimal results. iBeacons:tm: enable you to understand indoor customer location and context with incredible accuracy. Easily manage deployment and configuration of iBeacons:tm: with the Pulsate cloud platform. Gain a deeper understanding of your mobile customers and a comprehensive view of each mobile campaign.
- LegitFit — LegitFit is there to help you from first sale to scale! Our leading software solution is everything you need to run & grow a successful business. It's easy to use, affordable, and integrates powerful tools for bookings, payments, and communication!
- Certification Europe — Certification Europe offers ISO Certification, Inspection and ISO Training solutions to drive compliance for our clients!
WxNW operates as an investment firm.
Show more...Investment focus
- Industry: Sales, Consumer, Marketing
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- UrbanFox — UrbanFox protects online retailers against new forms of stealth fraud by analysing and learning from existing legitimate and fraudulent customer behavioural patterns.
Blue Wire Capital (BWC) supports innovation by backing visionaries who want to change how the world works, primarily at pre-seed and seed. BWC provides exceptional founders and outstanding managers with fast & flexible access to capital, assistance, and a comprehensive network.
Show more...Investment focus
- Industry: Software, Art, Internet
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 29
- Round size: Seed $575k–$2.5M; Pre-Seed $550k–$4.3M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- RLTY — Metaverse Events Company
- beehiiv — Access the best tools available in email, helping your newsletter scale and monetize like never before.
- Anaphite — A breakthrough nanomaterial
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotech VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Ireland Biotech startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!